Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Noa Eliakim‐Raz, Barak Pertzov et al.|Clinical Infectious Diseases|2018Cited by 424
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Leonard Leibovici, Fidi Koppel et al.|PLoS ONE|2021Cited by 3
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, Leonard Leibovici, Fidi Koppel et al.|Gerontology|2022Cited by 2
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Leonard Leibovici, Fidi Koppel et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2021Cited by 0
Supplementary Material for: External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative BacteremiaAdi Turjeman, L. Leibovici, Fidi Koppel et al.|Figshare|2022Cited by 0